Significant reduction of peripheral blood interleukin-35 and CD4(+)EBI3(+) T cells, which are negatively correlated with an increase in the plasma IL-17 and cTnI level, in viral myocarditis patients

病毒性心肌炎患者外周血白细胞介素-35和CD4(+)EBI3(+) T细胞显著减少,且与血浆IL-17和cTnI水平升高呈负相关。

阅读:1

Abstract

INTRODUCTION: Viral myocarditis (VMC) has become an increasingly common heart disease that endangers human health. In the present study, the plasma interleukin-35 (IL-35) level and the percentage of CD4(+)EBI3(+) T cells in VMC patients were detected to investigate the significance of changes in these parameters in the plasma of VMC patients and their association with the disease. MATERIAL AND METHODS: ELISA was performed to detect the plasma IL-35 level and the percentage of peripheral blood CD4(+)EBI3(+) T cells in 40 VMC patients and in 20 healthy individuals. Moreover, the plasma IL-17 levels in the VMC patients and in the healthy individuals were detected using an ELISA, and the cardiac Troponin-I (cTnI) levels were detected using a chemiluminescent microparticle immunoassay to compare the differences in the groups. RESULTS: Plasma IL-35 level and the percentage of CD4 (+) EBI3 (+) T cells in acute phase VMC patients was lower than that in the healthy control group and the convalescent phase VMC patients. Additionally, the plasma IL-35 level in the VMC patients exhibited a negative correlation with the levels of cTnI and IL-17. The percentage of CD4(+)EBI3(+) T cells also showed a negative correlation with the levels of cTnI and IL-17. CONCLUSIONS: The plasma IL-35 level and the percentage of CD4(+)EBI3(+) T cells in VMC patients was reduced, and the amount of the decrease was associated with the severity of the disease. These results suggest that IL-35 and CD4(+)EBI3(+) T might play important roles in the progression of VMC and could be used as indictors of the disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。